Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Robert J Henning Added: 3 years ago
Myocardial infarction (MI) is the leading cause of death among people in the industrialised world and will, according to the World Health Organization (WHO), become the leading cause of death in the world in 2020.1 For the treatment of patients with MIs and ischaemic cardiomyopathies, remarkable medical advances have been made during the second half of the 20th Century that have increased patient… View more
Author(s): Christian Homsy Added: 3 years ago
Cardiovascular disease (CVD) is the largest cause of mortality in the world, before cancer and infectious diseases. World Health Organization statistics for 2008 show that close to one in three deaths (29 %) in the world is due to CVD, representing more than 17 million per year. Cardiac diseases represent around 60 % of CVDs and are the single largest cause of death in the CVD population. Cardiac… View more
Author(s): Alexandra A MacLean , Barry T Katzen Added: 3 years ago
Abdominal aortic aneurysms remain a challenging diagnosis for patients. Over the last 18 years, the minimally invasive endovascular approach has developed into a viable alternative to traditional open surgery for the treatment of these abnormal aortic dilatations. Endovascular aneurysm repair (EVAR) is the preferred method of repairing abdominal aneurysms in older and high-risk patients. EVAR has… View more
Author(s): Robert J Hinchliffe , Krassi Ivancev Added: 3 years ago
Randomised trials in the infra-renal abdominal aorta have demonstrated endovascular is better than open repair in preventing aneurysm-related death up to four years post-operatively. Patients with thoracic aneurysms potentially have even more to gain from the endovascular technique. Mortality rates from open thoracic aneurysm repair are three times higher than the infra-renal aorta. Furthermore,… View more
Author(s): Francesco Maisano , Antonio Colombo , Ottavio Alfieri Added: 3 years ago
Catheter-based interventions for mitral regurgitation are currently under clinical evaluation. They represent the natural evolution of surgical treatment, which has been characterised by a progressive decline of invasiveness from the traditional open-heart and open-chest procedures to minimally invasive video-assisted procedures (including robotic technology), with closed-heart solutions using… View more
Author(s): Ralph Stephan von Bardeleben , Paul Sorajja , Gilbert Tang , et al Added: 10 months ago
Severe tricuspid regurgitation is an urgent global healthcare challenge, affecting over 70 million individuals worldwide. The associated adverse outcomes and burdensome symptoms demand effective solutions. While surgical intervention and medical therapy have been the traditional approaches, a new era has dawned with transcatheter repair emerging as a game-changing option. In this on-demand… View more
Author(s): Stephan Baldus Added: 1 year ago
Prof Stephan Baldus (University of Köln Medical Center, DE) shares insights from the TriCLASP post-market study (NCT04614402). This postmarket clinical follow up study, presented at EuroPCR 2022, assessed the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System in transcatheter tricuspid valve repair. Discussion Points: 1. Unmet needs of patients with TR 2. Study… View more